AXGN trade ideas: every closed DuckWise idea on AxoGen, Inc.

DuckWise has published 1 idea on AxoGen, Inc. (AXGN, Stock) that has closed between October 2020 and November 2020. Each is listed below with the levels published before the position was taken and its result at close — 1 in profit, 0 at a loss.

1closed idea

1 / 0in profit / at a loss

+24.59%average result

34 daystypical holding period

Opened	Closed	Side	Entry	Stop	Projection	Close	Result	Days
Oct 6, 2020	Nov 9, 2020	Long	12.12	—	15.50	15.10	+24.59%	34

Prices in US dollars. Result is the price change from the published entry to the published close, before fees, taxes and slippage. How results are counted.

About AxoGen, Inc.

Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. Does not pay dividends.

These are closed ideas, published for the record. They are general and impersonal research, not a recommendation to buy or sell AXGN or any other security.